Stockscreener 앱 받기
1.96
8.89%
0.16
시간 외 거래:
1.96
전일 마감가:
$1.80
열려 있는:
$1.8
하루 거래량:
4.20M
Relative Volume:
5.73
시가총액:
$262.68M
수익:
$108.81M
순이익/손실:
$-186.70M
주가수익비율:
-2.3278
EPS:
-0.842
순현금흐름:
$-16.83M
1주 성능:
+20.25%
1개월 성능:
+29.80%
6개월 성능:
+37.06%
1년 성능:
+28.10%
1일 변동 폭
$1.49
$1.98
1주일 범위
$1.49
$1.99
52주 변동 폭
$0.85
$2.0787
Organigram Global Inc Stock (OGI) Company Profile
명칭
Organigram Global Inc
전화
-
주소
-
OGI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OGI
Organigram Global Inc
|
1.96 | 241.24M | 108.81M | -186.70M | -16.83M | -0.842 |
|
ZTS
Zoetis Inc
|
123.23 | 53.32B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.53 | 46.16B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.85 | 43.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.10 | 34.57B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
500.00 | 21.54B | 3.08B | 1.24B | 1.07B | 25.61 |
Organigram Global Inc Stock (OGI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-17 | 재개 | Canaccord Genuity | Speculative Buy |
| 2024-04-15 | 업그레이드 | Alliance Global Partners | Neutral → Buy |
| 2023-01-13 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-12 | 업그레이드 | Canaccord Genuity | Hold → Speculative Buy |
| 2021-05-11 | 업그레이드 | CIBC | Sector Underperform → Neutral |
| 2021-04-14 | 다운그레이드 | CIBC | Neutral → Sector Underperform |
| 2021-04-08 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
| 2021-03-10 | 다운그레이드 | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-13 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2021-01-13 | 다운그레이드 | Canaccord Genuity | Speculative Buy → Hold |
| 2020-07-07 | 개시 | Alliance Global Partners | Buy |
| 2020-01-15 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-01-13 | 개시 | BofA/Merrill | Underperform |
| 2020-01-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-11 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
Organigram Global Inc 주식(OGI)의 최신 뉴스
Organigram Global Inc (OGI) Q4 2025 Earnings Call Highlights: Record Revenue and Market ... - Yahoo Finance
Organigram Global (TSX:OGI) Valuation Check Ahead TSX Smallcap Index Update - Kalkine Media
Organigram’s net revenue climbs in 2025, fuelled by domestic and international sales - StratCann
OrganiGram (OGI) Reports Q4 Loss, Beats Revenue Estimates - sharewise.com
Organigram Q4 Net Loss Widens, Revenue Jumps - 富途牛牛
Earnings call transcript: OrganiGram Q4 2025 sees revenue surge, stock up premarket - Investing.com
OrganiGram: Fiscal Q4 Earnings Snapshot - KVUE
Organigram Global (OGI) Reports Increased Q4 Net Loss Despite Re - GuruFocus
Organigram (OGI) Reports Strong Q4 with Strategic Global Expansi - GuruFocus
Organigram Achieves Record Financial Results and Expands Market Leadership - TipRanks
Organigram Brief: Q4 Net Revenue $80.1 million - marketscreener.com
Press Release: Organigram Reports Record Fourth Quarter and Fiscal 2025 Results - 富途牛牛
A Glimpse of OrganiGram Holdings's Earnings Potential - Benzinga
Cannabis Stocks To Follow TodayDecember 11th - MarketBeat
Organigram (OGI) Set for Significant Revenue Growth in FQ4 - GuruFocus
Even after rising 16% this past week, Organigram Global (TSE:OGI) shareholders are still down 63% over the past five years - simplywall.st
Wall Street Zen Upgrades Organigram Global (NASDAQ:OGI) to Hold - MarketBeat
Cannabis stocks surge after reports of Trump planning to ease federal restrictions - Yahoo! Finance Canada
Trump Reportedly Plans Major Shift To Ease Federal Marijuana Rules - Benzinga
Peak Processing Secures Key Agreement with Organigram for THC Beverages - TipRanks
Organigram Global (OGI) Projected to Post Earnings on Tuesday - MarketBeat
Organigram Inc. Names James Yamanaka as CEO - Prepared Foods magazine
Is Organigram Global Stock Built to Withstand a Pullback? - Trefis
Is Organigram Global Inc a good long term investmentHealthcare Stock Analysis & Low Cost Wealth Building - earlytimes.in
Stocks in play: Organigram Global Inc. - The Globe and Mail
Organigram to Announce Q4 2025 Earnings on December 16 - TipRanks
Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025 - The Globe and Mail
Will Organigram Global Inc. (0OG) stock test record highs in 20252025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - Newser
How Organigram Global Inc. stock reacts to job market dataWeekly Trend Summary & Target Return Focused Picks - Newser
Organigram Appoints New CEO to Drive Global Growth - TipRanks
Will Organigram Global Inc. (0OG) stock beat growth indexes2025 Price Action Summary & Consistent Profit Focused Trading Strategies - Newser
Is Organigram Global Inc. (0OG) stock overpriced at current multiplesShort Setup & Technical Analysis for Trade Confirmation - Newser
Top Cannabis Stocks Worth WatchingNovember 29th - MarketBeat
OGI (Organigram Global) EV-to-EBITDA : -388.57 (As of Dec. 02, 2025) - GuruFocus
Will Organigram Global Inc. (0OG) stock gain from lower interest ratesWeekly Profit Analysis & Long-Term Safe Investment Plans - Newser
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Best Cannabis Stocks To Add to Your WatchlistNovember 25th - MarketBeat
Organigram upgrades lighting, premier ponders adding cannabis to interprovincial trade deal - CBC
James Yamanaka Named CEO of Organigram - mg Magazine
Organigram aims to boost crop yields, productivity with government support - StratCann
Organigram taps James Yamanaka as CEO - MSN
[6-K] ORGANIGRAM GLOBAL INC. Current Report (Foreign Issuer) | OGI SEC FilingForm 6-K - Stock Titan
Organigram Announces Appointment Of Chief Executive Officer >OGI.T - 富途牛牛
Organigram appoints former BAT executive as new CEO By Investing.com - Investing.com Nigeria
Organigram Global Inc. Appoints Peter Amirault as Executive Chair, Effective from December 1, 2025 - marketscreener.com
Organigram Announces Appointment of James Yamanaka as Chief Executive Officer, Effective on or About January 15, 2026 - MarketScreener
BTI Executive James Yamanaka to Lead Organigram Global as New CE - GuruFocus
Organigram appoints former BAT executive as new CEO - Investing.com India
Organigram Global Inc (OGI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.68%
1.28%
자본화:
|
볼륨(24시간):